Achieve Life Sciences Inc (NASDAQ:ACHV)
| 4.95 Delayed Data As of Aug 08 |  +0.024 / +0.48%Today’s Change | 4.81 Today|||52-Week Range 10.09 | -36.38% Year-to-Date |
Latest ACHV News | Press Releases
No recent news for Achieve Life Sciences Inc.
Today’s Trading
| Previous close | 4.96 |
| Today’s open | 5.00 |
| Day’s range | 4.95 - 5.05 |
| Volume | 46,525 |
| Average volume (3 months) | 68,101 |
| Market cap | $48.2M |
Data as of 3:59pm ET, 08/08/2022
Growth & Valuation
| Earnings growth (last year) | +24.64% |
| Earnings growth (this year) | +17.02% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.68 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MBRXMoleculin Biotech In... | +0.03 | +1.76% |
| DMACDiaMedica Therapeuti... | +0.09 | +5.33% |
| MRKRMarker Therapeutics ... | +0.02 | +4.07% |
| CYCNCyclerion Therapeuti... | +0.25 | +27.76% |
Data as of 3:59pm ET, 08/08/2022
Financials
| Next reporting date | August 12, 2022 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Vancouver, British Columbia |
Forecasts
